Real-World study reveals how doctors treat tough colorectal cancer
NCT ID NCT04317599
First seen Jan 08, 2026 · Last updated Jun 02, 2026 · Updated 20 times
Summary
This study looked back at medical records of 274 patients in Europe with a specific genetic mutation (BRAF V600E) in advanced colorectal cancer that had spread. The goal was to see what treatments doctors actually used and how well they worked in everyday practice, not in a controlled trial. The findings help put new experimental treatments into context and may guide future care decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AUSL-IRCCS of Reggio Emilia-Clinical Cancer Center
Reggio Emilia, Italy
-
AZ Klina
Brasschaat, Belgium
-
Asst Valle Olona
Saronno, Italy
-
Azienda Ospedaliero-Universitaria Pisana
Pisa, Italy
-
Barmherzige Brüder Krankenhaus St. Veit/Glan.
Saint Veit/Glan, Austria
-
CHC MontLégia
Liège, Belgium
-
CHRU de Besançon
Besançon, France
-
CHU Grenoble Alpes
La Tronche, France
-
CHU de Poitiers
Poitiers, France
-
Centre Oscar Lambert
Lille, France
-
Clinica Oncologica Ospedali Riuniti di Ancona
Ancona, Italy
-
Facharztzentrum Eppendorf
Hamburg, Germany
-
GHPSO (Groupe Hospitalier Sud de l'Oise)
Creil, France
-
Gustave Roussy
Villejuif, France
-
Harrogate & District NHS Foundation Trust
Harrogate, United Kingdom
-
Hospital General Universitario de Valencia
Valencia, Spain
-
Hospital del Mar
Barcelona, Spain
-
Hôpital Franco-Britannique
Levallois-Perret, France
-
ICM Val d'Aurelle
Montpellier, France
-
Imelda VZW
Bonheiden, Belgium
-
Imperial College Healthcare NHS Trust
London, United Kingdom
-
Instituto Nazionale Tumori, IRCCS, Fondazione G. Pascale
Naples, Italy
-
Klinikum Aschaffenburg Medical Klinik IV
Aschaffenburg, Germany
-
La Paz University Hospital
Madrid, Spain
-
MVZ Mitte Leipzig
Leipzig, Germany
-
MZ Onkologie Velbert/Ratingen/Mettmann
Velbert, Germany
-
Medizinische Universität Wien
Vienna, Austria
-
Oncoresearch Lerchenfeld
Hamburg, Germany
-
Santa Maria Goretti Hospital
Latina, Italy
-
Studienzentrale Gokos
Dresden, Germany
-
UZ Leuven
Leuven, Belgium
-
University College London Hospitals NHS Foundation Trust
London, United Kingdom
-
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
-
Universitätsklinikum Essen
Essen, Germany
Conditions
Explore the condition pages connected to this study.